Methods for treating immunomediated inflammatory disorders
US6323219A · kind A · utility
65Cited by
1References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 27, 1999 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Jan 27, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods ands compositions for bringing about changes in skin pigmentation and for treating inflammatory disorders. More particularly, this invention relates to compounds which affect melanogenesis and can be used as depigmenting agents or as agents for darkening skin utilizing the PAR-2 pathway and compounds for the, prevention and treatment of immunomediated inflammatory diseases, particularly those associated with the respiratory tract, such as asthma and allergic rhinitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.